
Seneca Biopharma, Inc. SNCA
Seneca Biopharma, Inc. Betriebszyklus | SNCA
Betriebszyklus Jährlich Seneca Biopharma, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.3 | - | 58.5 | 57.2 | 61.1 | 80.2 | 49.6 | - | 46.6 | 44.9 | 37.4 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 80.2 | 24.3 | 51.1 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Sangamo Therapeutics
SGMO
|
4.14 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
382 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
8.21 | - | - | $ 826 K | ||
|
Vaxart
VXRT
|
187 | - | -25.06 % | $ 46.3 M | ||
|
XOMA Corporation
XOMA
|
23.6 | - | - | $ 485 M | ||
|
Sesen Bio
SESN
|
391 | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
164 | - | - | $ 26.8 M | ||
|
SQZ Biotechnologies Company
SQZ
|
25.5 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
392 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
6.22 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B | ||
|
AbbVie
ABBV
|
350 | $ 294.72 | 0.32 % | $ 521 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
33.4 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Axon Enterprise
AXON
|
98.8 | $ 316.97 | 4.77 % | $ 24.7 B | ||
|
Bristol-Myers Squibb Company
BMY
|
153 | $ 62.89 | 0.18 % | $ 128 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
19.1 K | - | -15.15 % | $ 60.3 M | ||
|
Dynavax Technologies Corporation
DVAX
|
512 | - | - | $ 2.02 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
86.7 | $ 159.75 | 5.35 % | $ 20.9 B | ||
|
Amgen
AMGN
|
282 | $ 467.97 | 0.59 % | $ 252 B | ||
|
Orgenesis
ORGS
|
25.8 | - | -33.86 % | $ 61.2 M | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
66.2 | $ 248.31 | 1.17 % | $ 15.1 B | ||
|
Johnson & Johnson
JNJ
|
223 | $ 280.31 | -0.17 % | $ 675 B | ||
|
Kala Pharmaceuticals
KALA
|
729 | $ 0.17 | 0.64 % | $ 1.39 M |